EUVIMEDEUVIMED entdecken
Crossref

Chemoenzymatic assembly of structurally defined heparan sulfate oligosaccharides reveals heparanase substrate plasticity and enables inhibitor design

Xiao Wang, Qinyu Liu, Guijiao Zhang, Aohui Liu, Yanzhen Cheng, Qiuhan Xu, Jiukun Liu, Chunhui Liu

Bioorganic Chemistry · 2026

DOI: 10.1016/j.bioorg.2026.110358 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026. Verfasst von Xiao Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Institute of Biochemical and Biotechnolog…. Hauptthemen laut MEDLINE: Heparan Sulfate, Glucuronidase, Oligosaccharides, Enzyme Inhibitors. Die Arbeit nennt 39 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heparanase (HPSE) is a promising therapeutic target, yet current heparin-derived inhibitors are limited by structural heterogeneity, poor selectivity, and off-target anticoagulant effects. Here, we synthesized a library of structurally defined heparan sulfate (HS) oligosaccharides via a robust chemoenzymatic strategy, enabling a systematic investigation of HPSE cleavage specificity. Our data confirm the minimal cleavable tetrasaccharide motif for HPSE and the preference for the endolytic site proximal to the nonreducing end in HS hexasaccharides. We demonstrate that a 2-O-sulfated iduronic acid (IdoA2S) residue confers susceptibility to HPSE cleavage on 6-O-nonsulfated HS oligosaccharides through compensatory interactions with the enzyme's heparin-binding domain (HBDs), and acts synergistically with 6-O-sulfated GlcNS residues to promote catalytic efficiency. HPSE exhibits an atypical exo-type cleavage at the nonreducing-terminal GlcA residue, dependent on sulfation patterns and chain length, challenging the traditional classification of HPSE as a strictly endo-acting β-glucuronidase. Leveraging insights into substrate plasticity, we rationally designed highly sulfated HS oligosaccharides, each featuring a disfavored terminal GlcA motif linked to an IdoA2S-enriched sequence. A 3-O-sulfated HS nonasaccharide 28 exhibited sub-micromolar HPSE inhibitory potency (IC50 = 0.761 μM) and is expected to minimize anticoagulant liabilities by lacking the canonical antithrombin-binding sequence. Collectively, this work elucidates the molecular determinants of HPSE substrate plasticity and provides a structure-based foundation for the rational design of next-generation anti-metastatic agents with improved selectivity and safety profiles.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heparan SulfateGlucuronidaseOligosaccharidesEnzyme InhibitorsDrug DesignHeparanaseHumansSubstrate SpecificityStructure-Activity RelationshipMolecular Structure

Stichwörter der Autor:innen

Chemoenzymatic synthesisExo-type cleavageHeparan sulfate oligosaccharidesHeparanaseO-sulfationRational inhibitor designSubstrate plasticity

Substanzen

Heparan SulfateGlucuronidaseHeparanaseOligosaccharidesEnzyme Inhibitors

Autor:innen und Institutionen

  • State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Institute of Biochemical and Biotechnological Drugs, School of Pharmaceutical Sciences, Cheeloo College of Medi…

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China

Zitieren

APA

Wang, X., Liu, Q., Zhang, G., Liu, A., Cheng, Y., Xu, Q., Liu, J., & Liu, C. (2026). Chemoenzymatic assembly of structurally defined heparan sulfate oligosaccharides reveals heparanase substrate plasticity and enables inhibitor design. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2026.110358

Vancouver

Wang X, Liu Q, Zhang G, Liu A, Cheng Y, Xu Q, et al. Chemoenzymatic assembly of structurally defined heparan sulfate oligosaccharides reveals heparanase substrate plasticity and enables inhibitor design. Bioorganic Chemistry. 2026. doi:10.1016/j.bioorg.2026.110358

BibTeX
@article{Wang2026,
  author = {Wang, Xiao and Liu, Qinyu and Zhang, Guijiao and Liu, Aohui and Cheng, Yanzhen and Xu, Qiuhan and Liu, Jiukun and Liu, Chunhui},
  title = {Chemoenzymatic assembly of structurally defined heparan sulfate oligosaccharides reveals heparanase substrate plasticity and enables inhibitor design},
  journal = {Bioorganic Chemistry},
  year = {2026},
  doi = {10.1016/j.bioorg.2026.110358}
}
Kostenlos starten →